Madrigal Pharma (MDGL) option IV into FDA approves Madrigal Pharmaceuticals' Rezdiffra
Go back to Madrigal Pharma (MDGL) option IV into FDA approves Madrigal Pharmaceuticals' Rezdiffra| (NASDAQ: MDGL) | Delayed: 530.00 +10.91 (2.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $519.09 | 52 Week High | $18.24 | |||
| Open | $520.09 | 52 Week Low | $6.60 | |||
| Day High | $530.09 | P/E | N/A | |||
| Day Low | $519.00 | EPS | $0.00 | |||
| Volume | 33,310 | |||||

